ONCOTARGET: THE MEDICAL JOURNAL

Oncotarget is a medical journal that majors in oncology. Oncology is a branch of medicine that deals with treatment, analysis, and prevention of cancer. Impact journals published Oncortaget and established in 2010.

Mikhail Blagosklononny and Andrei V. Gudkov were the first chief editor of the medical journal. The editors are now based at Rosewall Park Cancer Institute. The medical journal is significantly talented and resourceful for scientific results and research on cancer. It helps both doctors and a regular citizen to have a better understanding of how to fight and handle the condition. In 2015 Oncortaget was ranked number one the listing of oncology journals in the United States.

The primary motive of Oncortaget as a firm is the best example one can refer to scientific research of oncology. Adding on the same token, recently one of the study papers that were researched, published, developed included the impact of Hur impediment by small molecule on collateral cancer cell called tumorigenesis. The condition, cancer is one of disease that has a high mortality rate,i.e. cancer was placed third as the most common cancer that causes cancer to have a high mortality rate. Oncortaget is a platform that was created to help people give in their suggestion and also interact with highly trained doctors to come up with a better solution on how to combat the disease. Follow Oncotarget on Twitter.

The study carried out indicates that therapeutic outcomes target HuR in CRC that guarantees better results. But it’s important to note that Oncortahget plays a vital role in the entire society of the people either infected or affected by cancer. The Oncortaget provides more information on prevention and treatment by cancer.

Visit his profile on Google Scholar.